Clinical Trials Directory

Trials / Completed

CompletedNCT07202962

Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis

Study of Prevalence of Inappropriate Prescriptions in Hospitalized Elderly Patients According to STOPP&Amp;START Criteria (Screening Tools of Older Person Prescriptions and Screening Tool to Alert to Right Treatment) - SPIna Protocol

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Regione del Veneto - AULSS n. 7 Pedemontana · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

Evaluate the prevalence of potentially inappropriate prescriptions (PIPs) and potential omitted prescriptions (PPOs) in elderly patient upon admission to the acute geriatric department, based on adherence or non-adherence to the recommendations specified in STOPP and START criteria.

Conditions

Interventions

TypeNameDescription
DRUGmedication review and deprescribingThe study protocol includes the following assessments: * T0: first data collection upon admission to the ward; * T1 assessment: pharmacological review at discharge. Subjects who meet all study eligibility criteria will come consecutively enrolled in the study during admission to the department (T0). By consulting the electronic health record, interviewing patients and family members and personal documentation, the following data will be collected: * Remote and immediate pathological history; * Family and social history; * Home therapy; * BRIEF-MPI. Home therapy and therapy suggested at discharge will be compared with the STOPPandSTART criteria to evaluate the prevalence of potential therapies inappropriate and to study possible interactions and contraindications pharmacological and for reporting possible adverse reactions to drugs. The prevalence and possible prevalence of each individual STOPPandSTART criterion will be assessed association with other variables of interest.

Timeline

Start date
2024-07-17
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2025-10-02
Last updated
2025-10-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07202962. Inclusion in this directory is not an endorsement.